L04AB01 |
BioTech |
Etanercept - 50mg |
9755 |
53119/1 |
ERELZI |
50mg |
4 |
Injectable solution |
SC |
Khalil Fattal & Fils S.A.L. |
Sandoz GmbH, (Schaftenau) |
Austria |
53,752,106 L.L |
10.71 |
E1 |
Sandoz GmbH, Kundl |
Austria |
03/04/20 |
|
L04AB01 |
BioTech |
Etanercept - 50mg |
9756 |
53019/1 |
ERELZI |
50mg |
4 |
Injectable solution |
SC |
Khalil Fattal & Fils S.A.L. |
Sandoz GmbH, (Schaftenau) |
Austria |
37,174,909 L.L |
10.71 |
E1 |
Sandoz GmbH, Kundl |
Austria |
03/04/20 |
|
L04AB01 |
BioTech |
Etanercept - 50mg |
10398 |
165119/1 |
ENBREL |
50mg |
4 |
Injectable solution |
SC |
Food & Drug Corporation FDC |
Pfizer Manufacturing Belgium NV |
Belgium |
52,197,598 L.L |
10.71 |
E1 |
Pfizer Europe MA EEIG |
Belgium |
03/04/20 |
|
L04AB01 |
BioTech |
Etanercept - 50mg |
10399 |
117119/1 |
ENBREL |
50mg |
4 |
Injectable solution |
SC |
Food & Drug Corporation FDC |
Pfizer Manufacturing Belgium NV |
Belgium |
52,197,598 L.L |
10.71 |
E1 |
Pfizer Europe MA EEIG |
Belgium |
03/04/20 |
|
L04AB01 |
BioTech |
Etanercept - 50mg/1ml |
10377/388 |
138419/1 |
ALTEBREL |
50mg/1ml |
4 |
Injectable solution |
SC |
Lebiran SARL |
Aryogen Pharmed |
Iran |
L.L |
10.71 |
E1 |
Aryogen Pharmed |
Iran |
05/02/20 |
|